Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep 6;11(1):17717.
doi: 10.1038/s41598-021-96146-5.

Prognostic factors in elderly patients with T1 glottic cancer treated with radiotherapy

Anna Mucha-Małecka  1 , Krzysztof Małecki  2   3 , Natalia Amrogowicz  4 , Beata Biesaga  5   6 , Maciej Modrzejewski  7   8
Affiliations

Prognostic factors in elderly patients with T1 glottic cancer treated with radiotherapy

Anna Mucha-Małecka et al. Sci Rep. .

Abstract

The aim of the study was the evaluation of the effectiveness of radiotherapy in elderly T1 glottic cancer patients and prognostic factors with particular focus on comorbidities. Five-year overall survival, disease-specific survival, and local control rates were 63%, 92%, and 93%, respectively. Multivariate analysis showed that the following factors had statistically significant impact on local relapse risk and cancer death risk: diabetes, underweight, and fraction dose of 2 Gy. High number of comorbidities, high CCI, and underweight negatively influenced overall survival. A retrospective analysis was performed in a group of 131 T1N0M0 glottic cancer patients aged 70 and above treated with irradiation at the National Institute of Oncology in Cracow between 1977 and 2007. In the analyzed group men prevailed (92%) of mean age of 74 years. Each patient was diagnosed with at least one comorbidity with the following comorbid conditions being most frequent: hypertension, ischemic heart disease, and chronic obstructive pulmonary disease. In the studied group, the effect of comorbidities on overall survival was evaluated using Charlson Comorbidity Index (CCI). Twenty five (19%) patients showed underweight. All patients were irradiated once daily, 5 days a week, to a total dose of 60-70 Gy with a fraction dose of 2 or 2.5 Gy. Radiotherapy is an effective treatment modality in elderly T1 glottic cancer patients. Diabetes as comorbidity, underweight, and conventional dose fractionation decrease the probability of curative effect of radiotherapy in this group of patients, while high number of comorbidities diminishes the probability of long-term survival.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
The probability of 5-year overall survival (OS) in T1 glottic cancer patients aged 70 and above.
Figure 2
Figure 2
The probability of 5-year disease-specific survival (DSS) in T1 glottic cancer patients aged 70 and above.
Figure 3
Figure 3
The probability of 5-year local control (LC) in T1 glottic cancer patients aged 70 and above.
Figure 4
Figure 4
The probability of 5-year overall survival (OS) in T1 glottic cancer patients aged 70 and above in relation to the number of comorbidities.
Figure 5
Figure 5
The probability of 5-year overall survival (OS) in T1 glottic cancer patients aged 70 and above in relation to the Charlson Comorbidity Index.
Figure 6
Figure 6
The probability of 5-year local control (LC) in T1 glottic cancer patients aged 70 and above in relation to diabetes.
Figure 7
Figure 7
The probability of 5-year disease-specific survival (DSS) in T1 glottic cancer patients aged 70 and above in relation to diabetes.
Figure 8
Figure 8
The probability of 5-year overall survival (OS) in T1 glottic cancer patients aged 70 and above in relation to diabetes.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Didkowska J, Wojciechowska U, Olasek P. Cancer in Poland in 2015. Krajowy Rejestr nowotworów. Center of Oncology, Maria Sklodowska-Curie Institute; 2017.
    1. Taylor SM, Kerr P, Fung K, et al. Treatment of T1b glottic SCC: Laser vs radiation: A Canadian multicenter study. J. Otolaryngol. Head Neck Surg. 2013;42(1):22. doi: 10.1186/1916-0216-42-22. - DOI - PMC - PubMed
    1. Yoo J, Lacchetti C, Hammond JA, Gilbert RW, Head and Neck Cancer Disease Site Group Role of endolaryngeal surgery (with or without laser) versus radiotherapy in the management of early (T1) glottic cancer: A systematic review. Head Neck. 2014;36(12):1807–1819. doi: 10.1002/hed.23504. - DOI - PubMed
    1. Abdurehim Y, Hua Z, Yasin Y, Xukurhan A, Imam I, Yuqin F. Transoral laser surgery versus radiotherapy: Systematic review and meta-analysis for treatment options of T1a glottic cancer. Head Neck. 2012;34(1):23–33. doi: 10.1002/hed.21686. - DOI - PubMed
    1. Warner L, Chudasama J, Kelly CG, et al. Radiotherapy versus open surgery versus endolaryngeal surgery (with or without laser) for early laryngeal squamous cell cancer. Cochrane Database Syst. Rev. 2014;12(12):CD002027. doi: 10.1002/14651858.CD002027.pub2. - DOI - PMC - PubMed